Arcadia Biosciences, Inc.
Headquarters Davis, X1
Financials
Prospectuses and Registrations
FORMNAMEDATE FILED
424B3Prospectus2/11/2026S-3Registration statement under Securities Act of 19331/28/2026RWRegistration Withdrawal Request1/20/2026425Prospectuses and communications, business combinations12/29/2025425Prospectuses and communications, business combinations8/14/2025S-4/ARegistration of securities, business combinations7/31/2025425Prospectuses and communications, business combinations5/8/2025
Proxies
FORMNAMEDATE FILED
DEF 14AOther definitive proxy statements11/19/2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material5/16/2024DEF 14AOther definitive proxy statements5/16/2024DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material4/25/2023DEF 14AOther definitive proxy statements4/25/2023DEF 14AOther definitive proxy statements1/6/2023PRE 14AOther preliminary proxy statements12/23/2022
News
FORMNAMEDATE FILED
8-KResults of Operations and Financial Condition3/26/20268-KFinancial Statements and Exhibits2/6/20268-KEntry into a Material Definitive Agreement1/14/20268-KTermination of a Material Definitive Agreement12/29/20258-KSubmission of Matters to a Vote of Security Holders12/23/20258-KResults of Operations and Financial Condition11/7/20258-KNews Release10/24/2025
Ownership